%0 Journal Article
%A Sardanelli, Francesco
%A Aase, Hildegunn S
%A Álvarez, Marina
%A Azavedo, Edward
%A Baarslag, Henk J
%A Balleyguier, Corinne
%A Baltzer, Pascal A
%A Beslagic, Vanesa
%A Bick, Ulrich
%A Bogdanovic-Stojanovic, Dragana
%A Briediene, Ruta
%A Brkljacic, Boris
%A Camps Herrero, Julia
%A Colin, Catherine
%A Cornford, Eleanor
%A Danes, Jan
%A de Geer, Gérard
%A Esen, Gul
%A Evans, Andrew
%A Fuchsjaeger, Michael H
%A Gilbert, Fiona J
%A Graf, Oswald
%A Hargaden, Gormlaith
%A Helbich, Thomas H
%A Heywang-Köbrunner, Sylvia H
%A Ivanov, Valentin
%A Jónsson, Ásbjörn
%A Kuhl, Christiane K
%A Lisencu, Eugenia C
%A Luczynska, Elzbieta
%A Mann, Ritse M
%A Marques, Jose C
%A Martincich, Laura
%A Mortier, Margarete
%A Müller-Schimpfle, Markus
%A Ormandi, Katalin
%A Panizza, Pietro
%A Pediconi, Federica
%A Pijnappel, Ruud M
%A Pinker, Katja
%A Rissanen, Tarja
%A Rotaru, Natalia
%A Saguatti, Gianni
%A Sella, Tamar
%A Slobodníková, Jana
%A Talk, Maret
%A Taourel, Patrice
%A Trimboli, Rubina M
%A Vejborg, Ilse
%A Vourtsis, Athina
%A Forrai, Gabor
%T Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey.
%D 2016
%U http://hdl.handle.net/10668/10575
%X EUSOBI and 30 national breast radiology bodies support mammography for population-based screening, demonstrated to reduce breast cancer (BC) mortality and treatment impact. According to the International Agency for Research on Cancer, the reduction in mortality is 40 % for women aged 50-69 years taking up the invitation while the probability of false-positive needle biopsy is  • EUSOBI and 30 national breast radiology bodies support screening mammography. • A first priority is double-reading biennial mammography for women aged 50-69 years. • Extension to 73-75 and from 40-45 to 49 years is also encouraged. • Digital mammography (not film-screen or computer radiography) should be used. • DBT is set to become "routine mammography" in the screening setting in the next future.
%K Breast cancer
%K Digital breast tomosynthesis (DBT)
%K Digital mammography
%K Population-based screening
%K Recall rate
%~